<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/aurx" ></link>
<id>urn:uuid:d94a1894-966c-9618-6c30-3abc7cee753d</id>
<updated>2026-10-05T08:17:09-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>AURX: JORDEN DAVID EMERSON (CEO,CFO,DIR) Bought (B) 789 Shares of NUO THERAPEUTICS INC for $1.07 on 8/27</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6462011" ></link>
<id>urn:uuid:44487c4e-9b1e-04f9-f408-7c68a31ecd1a</id>
<updated>2026-08-31T10:29:08-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: JORDEN DAVID EMERSON (CEO,CFO,DIR) Bought (JB*) 7,984 Shares of NUO THERAPEUTICS INC for $1.09 on 8/28</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6462012" ></link>
<id>urn:uuid:2e3753eb-49b5-93aa-78f3-b6db940569ed</id>
<updated>2026-08-31T10:29:08-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: JORDEN DAVID EMERSON (CEO,CFO,DIR) Acquired (JB) 8,773 Shares of NUO THERAPEUTICS INC for $1.07-$1.09 on 8/27-8/28</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6461943" ></link>
<id>urn:uuid:6660b4b9-c10c-b134-fd4a-6ecfde6eddbf</id>
<updated>2026-08-28T21:46:35-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: JORDEN DAVID EMERSON (CEO,CFO,DIR) Exercised 162,500 Options (OE) of NUO THERAPEUTICS INC for $1.00 on 6/30, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6437556" ></link>
<id>urn:uuid:aa73c367-47a4-a6ba-c199-5f81a2e506a8</id>
<updated>2026-07-02T21:02:37-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: PITTMAN SCOTT M (DIR,BO) Exercised 40k Options (OE) of NUO THERAPEUTICS INC for $1.00 on 6/30, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6437548" ></link>
<id>urn:uuid:a5b7eac9-2ec8-4f00-b9bd-32ee53d74647</id>
<updated>2026-07-02T21:00:41-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: WINZER C ERIC (DIR) Exercised 40k Options (OE) of NUO THERAPEUTICS INC for $1.00 on 6/30, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6437545" ></link>
<id>urn:uuid:5ba4496f-b1a9-f3d6-b34e-796b17f24d9f</id>
<updated>2026-07-02T20:59:39-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
<entry>
<title>AURX: JORDEN DAVID EMERSON (CEO,CFO,DIR) Acquired (JB) 13,245 Shares of NUO THERAPEUTICS INC for $1.10 on 6/5</title>
<link href="http://www.insiderinsights.com/company/aurx/nuo-therapeutics-inc/id-6421160" ></link>
<id>urn:uuid:352ab185-8882-af6a-b9b6-27919cec3517</id>
<updated>2026-06-05T18:34:26-04:00</updated>
<summary type="html" ><![CDATA[NUO THERAPEUTICS INC (AURX). Recent Price: $1.25. Mkt Cap:60.5mm. 10D Vol: 1,814]]></summary>
</entry>
</feed>